Affordability of cancer treatment for aging cancer patients in Singapore: An analysis of health, lifestyle, and financial burden

Supportive Care in Cancer

Volumn 21, Issue 12, 2013, Pages 3509-3517

  Chan, Alexandre ^a,b   Chiang, Yu Yan ^a   Low, Xiu Hui ^a   Yap, Kevin Yi Lwern ^a,c   Ng, Raymond ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^c NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

Cancer; Financial burden; Health related quality of life; Singapore; Targeted therapy; Treatment costs

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER PATIENT; CANCER THERAPY; COST CONTROL; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE COST; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULARLY TARGETED THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGAPORE;

AGE FACTORS; AGED; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; SINGAPORE;

EID: 84889091418     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-1930-4     Document Type: Article

References (27)

1. Singapore Department of Statistics (2010) Census of Population 2010 Statistical Release 1. Singapore Department of Statistics, Singapore
2. Ministry of Social and Family Development (1999) Inter-Ministerial Committee Report of the Aging Population 1999. Ministry of Social and Family Development, Singapore
3. Berger NA, Savvides P, Koroukian SM et al (2006) Cancer in the elderly. Trans Am Clin Climatol Assoc 117:147-55, discussion 55-6
4. Gonsalves W, Ganti AK (2010) Targeted anti-cancer therapy in the elderly. Crit Rev Oncol Hematol 1428:16
5. Joshi VD, Lim JF (2010) Health insurance in Singapore: who's not included and why? Singap Med J 51:399-405
6. Ministry of Health (2011) Costs and Financing. Singapore MoH, Singapore
7. Medifund (2013) Costs and financing. Singapore MoH, Singapore
8. Lim M-K (2004) Shifting the burden of health care finance: a case study of public-private partnership in Singapore. Health Policy 69:83-92
9. Ministry of Health Singapore (2007) Healthcare Financing. Ministry of Health Singapore, Singapore
10. Arozullah AM, Calhoun EA, Wolf M et al (2004) The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol 2:271-8
11. Meropol NJ, Schulman KA (2007) Cost of cancer care: issues and implications. J Clin Oncol 25:180-6
12. Herdman M, Gudex C, Lloyd A et al (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20:1727-36
13. Population Division DoEaSA, United Nations. World population prospects: the 2012 revision population database. New York: United Nations
14. Markman M, Luce R (2010) Impact on the cost of cancer treatment: an internet-based survey. J Oncol Pract 6:69-73
15. Houts PS, Lipton A, Harvey HA et al (1984) Nonmedical costs to patients and their families associated with outpatient chemotherapy. Cancer 53:2388-92
16. Chan A, Chen C, Chiang J et al (2012) Incidence of febrile neutropenia among early-stage breast cancer patients receiving anthracycline-based chemotherapy. Support Care Cancer 20:1525-32
17. Yap KY, Low XH, Chui WK et al (2012) Computational prediction of state anxiety in Asian patients with cancer susceptible to chemotherapy-induced nausea and vomiting. J Clin Psychopharmacol 32:207-17
18. Yap KY, Chan A, Chui WK (2009) Improving pharmaceutical care in oncology by pharmacoinformatics: the evolving role of informatics and the internet for drug therapy. Lancet Oncol 10:1011-9
19. Lauzier S, Maunsell E, De Koninck M et al (2005) Conceptualization and sources of costs from breast cancer: findings from patient and caregiver focus groups. Psychooncology 14:351-60
20. Shih V, Chiang JY, Chan A (2009) Complementary and alternative medicine (CAM) usage in Singaporean adult cancer patients. Ann Oncol 20:752-7
21. Chan A, Lin TH, Shih V et al (2012) Clinical outcomes for cancer patients using complementary and alternative medicine. Altern Ther Health Med 18:12-7
22. Tigue CC, Fitzner KA, Alkhatib M et al (2007) The value of innovation: the economics of targeted drugs for cancer. Target Oncol 2:113-9
23. Kim P (2007) Cost of cancer care: the patient's perspective. J Clin Oncol 25:228-32
24. Chan A (2001) Singapore's changing structure and the policy implications for financial security, employment, living arrangements and health care. Asian MetaCentre 3
25. Ng ACY, Phillips DR, Lee WK-m (2002) Persistence and challenges to filial piety and informal support of older persons in a modern Chinese society: a case study in Tuen Mun, Hong Kong. J Aging Stud 16:135-53
26. Gordon L, Scuffham P, Hayes S et al (2007) Exploring the economic impact of breast cancers during the 18 months following diagnosis. Psycho-Oncology 16:1130-9
27. Sharp L, Timmons A (2010) The financial impact of a cancer diagnosis National Cancer Registry Ireland 128